$NKTR Nektar Therapeutics: Movantik’s Approval Represents The Best Possible Outcome, Says Roth Capital http://www.smarteranalyst.com/2014/09/17/nektar-therapeutics-movantiks-approval-represents-the-best-possible-outcome-says-roth-capital/